James Greger

Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL

Li Liu, James Greger, Hong Shi et al. · Cancer Research · 2009 · 471 citations · Full text

Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by <i>NRAS</i> or <i>MEK</i> Mutations

James Greger, Stephen D. Eastman, Vivian Zhang et al. · Molecular Cancer Therapeutics · 2012 · 353 citations

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 347 citations · Full text

Evidence that Stable Retroviral Transduction and Cell Survival following DNA Integration Depend on Components of the Nonhomologous End Joining Repair Pathway

René Daniel, James Greger, Richard A. Katz et al. · Journal of Virology · 2004 · 103 citations · Full text

Viral Replication, Immunology, Transduction Efficiency +21

Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response

René Daniel, Gary D. Kao, Konstantin D. Taganov et al. · Proceedings of the National Academy of Sciences · 2003 · 100 citations · Full text